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SummAry
To assess the effectiveness of maxillomandibular adavancement for treatment of adults with obstructive sleep apnoea, we report the results 
obtained after maxillomandibular advancement. A group of 16 patients were studied before surgery, at 6 months after surgery and at follow-
up. The analysis included: upper airway endoscopy during mueller’s manoeuvre, lateral cephalometry, polysomnography and Epworth 
Sleepiness Scale. The results of surgical treatment were divided into “surgical success” and “surgical cure”. The former was defined as an 
Ahi < 20 events/hour and a > 50% reduction in Ahi after surgical procedure, while the latter was defined as an Ahi < 5 events/hour after 
surgical procedure. At follow-up, all patients had Ahi < 20 events/hour with a surgical success rate of 100%. The surgical cure rate was 
37.5%, with 6 patients having an Ahi < 5 events/hour. Surgical success and long term stability of outcomes confirm the efficacy and safety 
of mmA for treatment of obstructive sleep apnoea syndrome. however, a continuous follow-up of these patients is necessary to control 
their lifestyle and to detect possible relapse.
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riASSunTo
Obbiettivo del nostro studio è stato valutare l’efficacia dell’avanzamento maxillo-mandibolare come trattamento dell’apnea ostruttiva 
del sonno negli adulti. Sedici pazienti sono stati studiati prima dell’intervento chirurgico, a sei mesi dopo l’intervento ed al follow-up. 
L’analisi includeva: l’endoscopia delle vie aeree superiori durante la manovra di Mueller, la cefalometria laterale, la polisonnografia e la 
scala della sonnolenza di Epworth. I risultati del trattamento chirurgico sono stati riportati in termini di successo chirurgico (riduzione 
superiore al 50% dell’ AHI con valori inferiori a 20 eventi / ora) e successo terapeutico (AHI <5 eventi / ora dopo l’intervento chirurgico) 
Al follow up (T
2
) tutti i pazienti avevano AHI <20 eventi / h con un “successo chirurgico” del 100%. Il tasso di “successo terapeutico” 
è stato del 37,5%, con 6 pazienti con un AHI <5 eventi / h. Il successo chirurgico e la stabilità a lungo termine dei risultati confermano 
l’efficacia e la sicurezza dell’avanzamento maxillo-mandibolare per il trattamento della OSAS. Tuttavia, un continuo follow-up di questi 
pazienti è necessario per controllare il loro stile di vita e di rilevare eventuali possibili recidive. 
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Introduction
Continuous positive airway pressure therapy (CPAP) 
is first line treatment for patients with obstructive sleep 
apnoea syndrome (oSAS). CPAP prevents upper airway 
collapse, relieves symptoms such daytime sleepiness and 
decreases cardiovascular events 1 2. however, for various 
reasons this treatment has poor compliance 3. 
An alternative approach to the oSAS is upper airway 
surgery, with the goal of increasing the posterior airway 
space and decreasing resistance to airflow, removing the 
site or sites of upper airway collapse 4.
Different surgical approaches have been proposed, includ-
ing tracheostomy, uvulopalatopharyngoplasty, velouvulo-
pharyngeal lift, hyoid suspension, partial glossectomy, 
lingual suspension, tongue base resection, genioglossus 
advancement and maxillomandibular advancement 5-8.
Tracheostomy is the surgical treatment for oSA with a 
success rate of 100% because of by-pass of the site of 
collapse; it is indicated as a treatment of last resort af-
ter the failure of other surgical procedures. other surgical 
procedures have given results that are not always positive. 
The reported surgical success rate for soft tissue surgical 
procedures is approximately 40-60% 9.
maxillo-mandibular advancement (mmA) enlarges the 
pharyngeal space by expanding the skeletal framework 
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so that the soft tissue pharyngeal structures and tongue 
attach, resulting in reduced pharyngeal collapsibility  10. 
mmA is currently the most effective surgical treatment 
for management of oSA in adults 11 12. herein, we report 
the results obtained after mmA in a group of adult pa-
tients affected by oSAS. 
Materials and methods
Between 2004 and 2009, 16 patients (13 males and 3 fe-
males) with a mean age of 49.31 years (SD 8.22) diagnosed 
with oSAS underwent mmA. maxillary and mandibular 
advancements were obtained by le Fort i osteotomy and 
bilateral sagittal split osteotomy, respectively. Surgery was 
always performed by the same surgical team.
Concomitant to bimaxillary surgery, 5 patients underwent 
septoplasty/turbinoplasty; 1 was subjected to uvulopalat-
opharyngoplasty and 3 patients underwent simultaneously 
septoplasty/turbinoplasty and uvulopalatopharyngoplasty. 
Additional procedures included (1) piriform rim recontour-
ing, (2) anterior nasal spine modelling and (3) alar base 
cinch suture. no patients underwent genioplasty. 
osteosynthesis was performed using plates and monocorti-
cal/bicortical screws, as dictated by the magnitude of the 
advancements and the anatomic variations. To assess surgi-
cal success and outcomes, we evaluated both objective and 
subjective parameters before surgery (T0), at 6 months af-
ter surgery (T1) and at follow-up (T2). The average length 
of follow-up was 48.6 months (SD 25.1 months).
objective examinations were evaluated by upper airway fi-
broscopy during mueller’s manoeuvre, lateral cephalometry 
and polysomnography. Subjective examinations were evalu-
ated by the Epworth Sleepiness Scale (ESS) questionnaire.
With upper airway endoscopic evaluation, performed us-
ing a flexible fibre optic endoscope in the supine position 
during mueller’s manoeuvre, we assessed the localization 
of site/sites of collapse (n: nose, o: oropharynx, h: oy-
popharynx), pattern of collapse (c: circular, t: transversal, 
ap: antero-posterior) and grade of collapse (grade 0, 1, 2, 
3, 4) (noh classification) 13.
With lateral cephalometry, performed on latero-lateral tel-
eradiography by the same operator, we evaluated skeletal 
relationship by angular measurements (SnA, SnB) as 
well as the posterior air space (PAS) between the base of 
the tongue and the posterior wall of the pharynx 14.
using polysomnography, we evaluated the average 
number of apnoeas and hypopnoeas per hour during sleep 
(Ahi), the average number of oxyhaemoglobin desatu-
ration per hour during sleep (oDi) and the average time 




Data were analyzed using the paired Student’s t-test and 
AnovA post hoc analysis with Bonferroni’s correction 
considering p < 0.001 as statistically significant. 
This research was approved by our institution.
Results
Presurgical upper airway fibroscopy with mueller’s ma-
noeuvre identified oropharyngeal and hypopharyngeal 
collapse in all patients. The most frequent pattern of oro-
pharyngeal collapse was the circular type (o: c), and was 
observed in 14 patients (87.5%), while the most frequent 
pattern of hypopharyngeal collapse was the transversal 
type (h: t) and was observed in 10 patients (62.5%). At 
T1, we observed a reduction of the grade of collapse in all 
patients. From T1 to T2, we observed a worsening of the 
grade of collapse in 4 patients, although the T2 grade of 
collapse was less than the preoperative grade (T0); these 
patients had significant improvement in clinical outcomes 
(Table i). We referred these patients to sleep endoscopy.
For the cephalometric skeletal measurements (SnA and 
SnB), no statistically significant changes (p > 0.001) 
were observed from T1 to T2 (Table ii). These data con-
firmed long-term skeletal stability.
The posterior airway space (PAS) was increased in length 
from T0 to T1, respectively, from 3.73 mm (SD 2.1 mm) 
to 9.7mm (SD 2.7 mm) (p < 0.001). From T1 to T2, the 
differences in the PAS were not statistically significant 
(p > 0.001) (Table iii).
in Table iv, polysomnographic data is shown; from T0 to 
T1, there was a statistically significant decrease of Ahi, 
respectively, from 47.1 events/h (SD 22.5 events/h) to 
Table I. Upper airway endoscopic evaluation during Mueller’s manoeuvre. 
NOH (nose oropharynx hypopharynx) classification.
N O H
Pt. T0 T1 T2 T0 T1 T2 T0 T1 T2
1 0 0 0 1ap 1ap 1ap 2ap 2ap 1c
2 2 1 0 4c 2c 2c 3t 1t 1t
3 1 0 0 3-4c 2c 2c 2t 1t 1t
4 1 0 0 3-4c 1c 2c 3c 1c 1t
5 0 0 0 4c 2t 2t 4c 2c 2t
6 0 0 0 2c 0 0 3c 1c 1c
7 1 0 0 3c 1c 1t 2t 1t 1t
8 1 0 0 3t 2t 2c 3t 2t 2t
9 2 1 1 1t 1t 1t 2t 1t 1t
10 2 1 1 3c 1c 2c 4t 1t 1l
11 3 0 0 2c 2t 0 1t 1t 1t
12 2 0 0 4c 2ap 2ap 1ap 2ap 2ap
13 1 0 0 2c 1c 1ap 3c 1c 1c
14 3 0 0 4c 2c 2c 2t 1t 2c
15 3 0 0 4c 2c 3c 2c 2c 3c
16 2 0 0 3c 1c 1ap 3t 1c 2c
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16.1 events/h (SD 17.5 events/h) (p < 0.001). moreover, 
from T1 to T2 we observed a decrease in Ahi, but this 
change was not statistically significant (p > 0.001). The 
postoperative result remained stable over time. The oDi 
also maintained the same trends. Sao
2 
< 90% worsened 
from T1 to T2, (10 ± 18% vs 19.3 ± 39.3%). Comparing 
the saturation during wake before and after surgery, this 
result can be explained as a worsening of the clinical pic-
ture and not just as worsening of the sleep disorder. 
From T0 to T1, the ESS score had a statistically signifi-
cant reduction (12.93 ± 1.69 vs. 2.56 ± 1.99) (p < 0.001), 
while from T1 to T2 the difference in ESS score was 
not statistically significant (2.56 ± 1.99 vs 4.12 ± 2.52) 
(p > 0.001) (Table v).
Discussion
mmA is currently considered to be the craniofacial 
surgery that is most effective in treatment of oSAS in 
adults 11 12. The results of surgical treatment of oSAS are 
divided into “surgical success” and “surgical cure”. Sur-
gical success is defined as an Ahi < 20 events/hour and 
a > 50% reduction in Ahi 50% after surgical procedure. 
Surgical cure is defined as an Ahi < 5 events/hour after 
surgical procedure 15. 
holty and guilleminault performed a meta-analysis and 
systematic review to estimate the clinical efficacy of 
mmA in treating oSAS involving 627 adults with oSAS 
undergoing mmA 15. The mean Ahi decreased from 63.9 
events/hour to 9.5 events/hour following surgery. The 
surgical success and cure rates were 86.0  ±  30.9% and 
43.2 ± 11.7% respectively. They also observed the main-
tenance of surgical success at 44 months after surgery. 
in our study, at follow up (T2) all patients had Ahi < 20 
events/hour with a “surgical success” rate of 100%. The 
surgical cure rate was 37.5%, with 6 patients having an 
Ahi < 5 events/hour. These results are in agreement with 
data reported in the above-mentioned meta-analysis and 
confirm the efficacy of mmA. improvements in Ahi were 
stable over time. There were no significant changes be-
tween the data collected at 6 months (T1) and at follow-up 
(T2). At follow-up, Ahi sufferers had further a reduction 
in Ahi registered at T1; this trend, although not statisti-
cally significant, could be explained by oedema of the soft 
tissue that persists for several months after surgery.
We observed a significant improvement in daytime sleepi-
ness, and all patients had subjective benefits of mmA (Ta-
ble v).
The analysis of skeletal cephalometric values (SnA and 
SnB) at T1 and T2 did not show any statistically significant 
differences (p > 0.001), confirming the long-term stability 
of skeletal advancement. no patient had skeletal relapse. 
in agreement with literature reports, postoperative PAS 
(T1) showed a significant increase (3.73 ± 9.07 mm vs. 
2.1 ± 2.7 mm). At T2, PAS maintained stable values; the 
differences between measurements performed at T1 and 
at T2 were not statistically significant (p > 0.001). 
Even the endoscopic data are encouraging; in fact, all pa-
tients showed a reduction in the grade of collapse at T1. At 
T2, we observed a worsening of the grade of collapse in 4 
patients, despite the resolution of symptoms and significant 
reduction in Ahi. however, in these patients the T2 grade 
of collapse was less than the T0 grade. one probable ex-
planation lies in the extreme subjectivity of the assessment 
method, and we referred these patients to sleep endoscopy.
Skeletal advancement was 9.1 mm ± 1.3 mm for the max-
illa and 8.9 mm ± 1.8 mm for the mandible. lye et al. 
found a statistically significant correlation between the 
degree of maxillary advancement and reduction in Ahi 12. 
however, others have reported no association between the 
degree of maxillary advancement and improvement in Ahi 
after mmA 16. in our study, mmA was personalized to the fa-
cial characteristics of each patient, and probably a mmA of 1 
cm protects patients from relapse in both skeletal soft tissues. 
initially, mmA was practiced as a second stage of treat-
ment, after failure of previous nasal and/or oropharyngeal 
surgery 14, and as a first stage of treatment in patients with 
substantial craniofacial deformities 5 17. our study under-
Table II. Cephalometric skeletal measurements.
SNA SNB
T0 T1 T2 T0 T1 T2
Average 80.86 86.69 86.45 77.92 81.11 81.23
SD 3.95 4.32 3.95 3.41 3.43 3.91
Data are the angle of measure (°)
Table III. Cephalometric PAS measurements.
PAS
T0 T1 T2
Average 3.73 9.7 10.3
SD 2.1 2.7 2.3
Data are number (mm).
Table IV. Polysomnographic data.
T0 T1 T2
AHI 47.1 ± 22.5 16.1 ±17.5 10.4 ± 5.4
Supine AHI 41.1 ± 16.2 17.1 ± 24.2 12.6 ± 5.6
Lateral AHI 11.7 ± 14.0 5.2 ± 9.4 3.2 ± 4.7
ODI 20.4 ± 21.4 7.3 ± 10.1 6.6 ± 6.0
Sa < 90% 25.0 ± 7.0 10.0 ± 18.0 19.3 ± 39.3
Table V. ESS scores.
ESS
T0 T1 T2
Average 12.93 2.56 4.12
SD 1.69 1.99 2.52
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lines the possibility to extend mmA, as first stage treat-
ment, even in patients without dento-facial anomalies. 
however, this choice should also be guided by the sever-
ity of the disorder, severity of daytime symptoms, degree 
of pharyngeal collapse and restriction of PAS. 
mmA is generally safe with a major surgical complication 
maxillary (ischaemic necrosis, cardiac complication) rate 
of 1% 15, a minor complication (mandibular relapse, facial 
paraesthesia, tempor-mandibular joint disease) 15 18 19 rate 
of 3.1% and no reported deaths. immediately after sur-
gery, facial paresthesia was observed in 4 patients. At fol-
low-up however, no patients reported facial paraesthesia.
To reduce the excessive protrusion of maxilla and upper 
lip, we performed piriform rim recontouring, anterior 
nasal spine modelling and alar base cinch suture. in our 
study, no patients reported worsening of their appearance; 
13 patients showed a degree of rejuvenation after mmA 
and 3 reported no postoperative change.
Conclusions
oSAS is a chronic disease, and the goal of treatment is 
control of symptoms and control of oSAS-related risks 
by reducing the severity of the disorder. Surgical success 
and long-term stability of outcomes confirm the efficacy 
and safety of mmA for treatment of oSAS. however, 
continuous follow-up of these patients is necessary to 
control their lifestyle and detect possible relapse.
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